Literature DB >> 3086844

The human CK gene segment and the kappa deleting element are closely linked.

H G Klobeck, H G Zachau.   

Abstract

The element which mediates the deletion of the CK gene segment (abbreviations ref. 1) in human lambda light chain producing B-cells was found to be located 24 kb downstream of CK. The kappa deleting element is flanked by hepta- and nonanucleotide recognition sequences similar to the ones adjacent to the JK gene segments. Complementary recognition sequences with a 30 bp spacer were found in the JK-CK intron. For the first time the two partners of a recombination event in a mammalian immunoglobulin gene system have been linked on a physical map. The orientation of the recombination signals of the intron and the Kde sequences allows a joining by a simple deletion mechanism. Similarities and possible differences to the mechanism of V-J joining are discussed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3086844      PMCID: PMC311467          DOI: 10.1093/nar/14.11.4591

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  28 in total

1.  CYTOLOGY OF BURKITT'S TUMOUR (AFRICAN LYMPHOMA).

Authors:  J V PULVERTAFT
Journal:  Lancet       Date:  1964-02-01       Impact factor: 79.321

2.  An EBV-genome-negative cell line established from an American Burkitt lymphoma; receptor characteristics. EBV infectibility and permanent conversion into EBV-positive sublines by in vitro infection.

Authors:  G Klein; B Giovanella; A Westman; J S Stehlin; D Mumford
Journal:  Intervirology       Date:  1975       Impact factor: 1.763

3.  Production of free light chains of immunoglobulin by a hematopoietic cell line derived from a patient with multiple myeloma.

Authors:  Y Matsuoka; G E Moore; Y Yagi; D Pressman
Journal:  Proc Soc Exp Biol Med       Date:  1967 Aug-Sep

4.  Cytogenetic study of human lymphoid T-cell lines derived from lymphocytic leukemia.

Authors:  C C Huang; Y Hou; L K Woods; G E Moore; J Minowada
Journal:  J Natl Cancer Inst       Date:  1974-09       Impact factor: 13.506

5.  Surface IgM-kappa specificity on a Burkitt lymphoma cell in vivo and in derived culture lines.

Authors:  E Klein; G Klein; J S Nadkarni; J J Nadkarni; H Wigzell; P Clifford
Journal:  Cancer Res       Date:  1968-07       Impact factor: 12.701

Review 6.  Origin of immune diversity: genetic variation and selection.

Authors:  T Honjo; S Habu
Journal:  Annu Rev Biochem       Date:  1985       Impact factor: 23.643

7.  Nonproductive kappa immunoglobulin genes: recombinational abnormalities and other lesions affecting transcription, RNA processing, turnover, and translation.

Authors:  D E Kelley; L M Wiedemann; A C Pittet; S Strauss; K J Nelson; J Davis; B Van Ness; R P Perry
Journal:  Mol Cell Biol       Date:  1985-07       Impact factor: 4.272

8.  Cloning and sequencing of a rearranged V lambda gene from a Burkitt's lymphoma cell line expressing kappa light chains.

Authors:  L H Sun; C M Croce; L C Showe
Journal:  Nucleic Acids Res       Date:  1985-07-11       Impact factor: 16.971

9.  Deletions of kappa chain constant region genes in mouse lambda chain-producing B cells involve intrachromosomal DNA recombinations similar to V-J joining.

Authors:  M W Moore; J Durdik; D M Persiani; E Selsing
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

10.  A mutant immunoglobulin light chain is formed by aberrant DNA- and RNA-splicing events.

Authors:  J G Seidman; P Leder
Journal:  Nature       Date:  1980-08-21       Impact factor: 49.962

View more
  24 in total

Review 1.  Receptor selection in B and T lymphocytes.

Authors:  D Nemazee
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

2.  Nucleotide sequence of the intron of the germline human kappa immunoglobulin gene connecting the J and C regions reveals a matrix association region (MAR) next to the enhancer.

Authors:  C Whitehurst; H R Henney; E E Max; H W Schroeder; F Stüber; K A Siminovitch; W T Garrard
Journal:  Nucleic Acids Res       Date:  1992-09-25       Impact factor: 16.971

3.  Deletion of human JK segments by site-specific recombination recognizing the conserved nonamer and heptamer sequences.

Authors:  T Nakatani; K Horigome; N Nomura; T Kondo; H Ohtsuka; H Noguchi; T Honjo
Journal:  Nucleic Acids Res       Date:  1990-09-25       Impact factor: 16.971

4.  Analysis of expressed and non-expressed IGK locus rearrangements in chronic lymphocytic leukemia.

Authors:  Chrysoula Belessi; Kostas Stamatopoulos; Anastasia Hadzidimitriou; Katerina Hatzi; Tatjana Smilevska; Niki Stavroyianni; Fotini Marantidou; George Paterakis; Athanasios Fassas; Achilles Anagnostopoulos; Nikolaos Laoutaris
Journal:  Mol Med       Date:  2005 Jan-Dec       Impact factor: 6.354

5.  Genomic organization and evolution of immunoglobulin kappa gene enhancers and kappa deleting element in mammals.

Authors:  Sabyasachi Das; Nikolas Nikolaidis; Masatoshi Nei
Journal:  Mol Immunol       Date:  2009-06-26       Impact factor: 4.407

6.  Reciprocal recombination products of VK-JK joining reactions in human lymphoid cell lines.

Authors:  S M Deev; G Combriato; H G Klobeck; H G Zachau
Journal:  Nucleic Acids Res       Date:  1987-01-12       Impact factor: 16.971

7.  A sequence homologous to kappa-deleting element is located 5' to the human JK locus.

Authors:  M A Kennedy; C M Morris; P H Fitzgerald
Journal:  Nucleic Acids Res       Date:  1989-01-25       Impact factor: 16.971

8.  The germ-line counterpart of a non-VK sequence rearranged to JK1 in MOPC41 is located on mouse chromosome 6.

Authors:  H G Klobeck; C A Kozak; H G Zachau
Journal:  Nucleic Acids Res       Date:  1988-07-25       Impact factor: 16.971

9.  Linking of the human immunoglobulin VK and JKCK regions by chromosomal walking.

Authors:  H G Klobeck; F J Zimmer; G Combriato; H G Zachau
Journal:  Nucleic Acids Res       Date:  1987-12-10       Impact factor: 16.971

10.  B cell receptor light chain repertoires show signs of selection with differences between groups of healthy individuals and SLE patients.

Authors:  Nathan Schoettler; Dongyao Ni; Martin Weigert
Journal:  Mol Immunol       Date:  2012-04-18       Impact factor: 4.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.